126 related articles for article (PubMed ID: 29540894)
1. Evidence of cognitive flexibility deficits and impaired emotion regulation in childhood survivors of acute lymphoblastic leukaemia: Findings from task switching study.
Gul A; Zafar S
J Pak Med Assoc; 2018 Mar; 68(3):848-486. PubMed ID: 29540894
[TBL] [Abstract][Full Text] [Related]
2. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
[TBL] [Abstract][Full Text] [Related]
3. Connectivity of the Cerebello-Thalamo-Cortical Pathway in Survivors of Childhood Leukemia Treated With Chemotherapy Only.
Phillips NS; Kesler SR; Scoggins MA; Glass JO; Cheung YT; Liu W; Banerjee P; Ogg RJ; Srivastava D; Pui CH; Robison LL; Reddick WE; Hudson MM; Krull KR
JAMA Netw Open; 2020 Nov; 3(11):e2025839. PubMed ID: 33216140
[TBL] [Abstract][Full Text] [Related]
4. Brain Activity Associated With Attention Deficits Following Chemotherapy for Childhood Acute Lymphoblastic Leukemia.
Fellah S; Cheung YT; Scoggins MA; Zou P; Sabin ND; Pui CH; Robison LL; Hudson MM; Ogg RJ; Krull KR
J Natl Cancer Inst; 2019 Feb; 111(2):201-209. PubMed ID: 29790971
[TBL] [Abstract][Full Text] [Related]
5. [Late sequelae of central nervous system prophylaxis in children with acute lymphoblastic leukemia: high doses of intravenous methotrexate versus radiotherapy of the central nervous system--review of literature].
Zając-Spychała O; Wachowiak J
Med Wieku Rozwoj; 2012; 16(2):128-37. PubMed ID: 22971657
[TBL] [Abstract][Full Text] [Related]
6. Evolution of neurocognitive function in long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only.
Liu W; Cheung YT; Conklin HM; Jacola LM; Srivastava D; Nolan VG; Zhang H; Gurney JG; Huang IC; Robison LL; Pui CH; Hudson MM; Krull KR
J Cancer Surviv; 2018 Jun; 12(3):398-406. PubMed ID: 29484542
[TBL] [Abstract][Full Text] [Related]
7. Effective prevention of central nervous system leukemia with intrathecal methotrexate and intrathecal methotrexate, cytosine arabinoside, and hydrocortisone in childhood acute lymphocytic leukemia.
Aur RJ; Hanna M; Sabbah R; Sackey K; Willoughby S; Atwood J
Haematol Blood Transfus; 1990; 33():504-10. PubMed ID: 2323651
[No Abstract] [Full Text] [Related]
8. Childhood leukemia survivors exhibit deficiencies in sensory and cognitive processes, as reflected by event-related brain potentials after completion of curative chemotherapy: A preliminary investigation.
Brace KM; Lee WW; Cole PD; Sussman ES
J Clin Exp Neuropsychol; 2019 Oct; 41(8):814-831. PubMed ID: 31156064
[No Abstract] [Full Text] [Related]
9. A Cross-sectional Study of Two Chemotherapy Protocols on Long Term Neurocognitive Functions in Egyptian Children Surviving Acute Lymphoblastic Leukemia.
Sherief LM; Sanad R; ElHaddad A; Shebl A; Abdelkhalek ER; Elsafy ER; Hassan TH; Raafat N; Kamal NM; Attia EI
Curr Pediatr Rev; 2018; 14(4):253-260. PubMed ID: 30381081
[TBL] [Abstract][Full Text] [Related]
10. Effects of early chemotherapeutic treatment on learning in adolescent mice: implications for cognitive impairment and remediation in childhood cancer survivors.
Bisen-Hersh EB; Hineline PN; Walker EA
Clin Cancer Res; 2013 Jun; 19(11):3008-18. PubMed ID: 23596103
[TBL] [Abstract][Full Text] [Related]
11. Early adolescent language development following intrathecal chemotherapy for acute lymphoblastic leukaemia.
Lewis FM; Bohan JK
Int J Speech Lang Pathol; 2018 Oct; 20(5):485-493. PubMed ID: 28394186
[TBL] [Abstract][Full Text] [Related]
12. Cognitive and behavioral risk factors for low quality of life in survivors of childhood acute lymphoblastic leukemia.
van der Plas E; Spencer Noakes TL; Butcher DT; Weksberg R; Galin-Corini L; Wanstall EA; Te P; Hopf L; Guger S; Hitzler J; Schachar RJ; Ito S; Nieman BJ
Pediatr Res; 2021 Aug; 90(2):419-426. PubMed ID: 33203967
[TBL] [Abstract][Full Text] [Related]
13. Evidence for cerebellar-frontal subsystem changes in children treated with intrathecal chemotherapy for leukemia: enhanced data analysis using an effect size model.
Lesnik PG; Ciesielski KT; Hart BL; Benzel EC; Sanders JA
Arch Neurol; 1998 Dec; 55(12):1561-8. PubMed ID: 9865801
[TBL] [Abstract][Full Text] [Related]
14. Inconsistencies between measures of cognitive dysfunction in childhood acute lymphoblastic leukemia survivors: Description and understanding.
Leclerc AA; Lippé S; Bertout L; Chapados P; Boulet-Craig A; Drouin S; Krajinovic M; Laverdière C; Michon B; Robaey P; Rondeau É; Sinnett D; Sultan S
Psychooncology; 2020 Jul; 29(7):1201-1208. PubMed ID: 32391960
[TBL] [Abstract][Full Text] [Related]
15. Motor and perceptual timing deficits among survivors of childhood leukemia.
Mahone EM; Prahme MC; Ruble K; Mostofsky SH; Schwartz CL
J Pediatr Psychol; 2007 Sep; 32(8):918-25. PubMed ID: 17522113
[TBL] [Abstract][Full Text] [Related]
16. No major cognitive impairment in young children with acute lymphoblastic leukemia using chemotherapy only: a prospective longitudinal study.
Kingma A; Van Dommelen RI; Mooyaart EL; Wilmink JT; Deelman BG; Kamps WA
J Pediatr Hematol Oncol; 2002 Feb; 24(2):106-14. PubMed ID: 11990695
[TBL] [Abstract][Full Text] [Related]
17. The effect of cardiorespiratory fitness and physical activity levels on cognitive functions in survivors of childhood acute lymphoblastic leukemia.
Gendron É; Caru M; Léveillé P; Sultan S; Robaey P; Lemay V; Drouin S; Bertout L; Andelfinger G; Krajinovic M; Laverdière C; Sinnett D; Lippé S; Curnier D
Pediatr Hematol Oncol; 2020 Oct; 37(7):582-598. PubMed ID: 32510265
[No Abstract] [Full Text] [Related]
18. Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report.
Kaleita TA; Reaman GH; MacLean WE; Sather HN; Whitt JK
Cancer; 1999 Apr; 85(8):1859-65. PubMed ID: 10223582
[TBL] [Abstract][Full Text] [Related]
19. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.
Millot F; Suciu S; Philippe N; Benoit Y; Mazingue F; Uyttebroeck A; Lutz P; Mechinaud F; Robert A; Boutard P; Marguerite G; Ferster A; Plouvier E; Rialland X; Behard C; Plantaz D; Dresse MF; Philippet P; Norton L; Thyss A; Dastugue N; Waterkeyn C; Vilmer E; Otten J;
J Clin Oncol; 2001 Apr; 19(7):1935-42. PubMed ID: 11283125
[TBL] [Abstract][Full Text] [Related]
20. Pediatric acute lymphoblastic leukemia: redefining outcomes.
Kadan-Lottick N; Neglia JP
J Pediatr Hematol Oncol; 2002 Feb; 24(2):88. PubMed ID: 11990711
[No Abstract] [Full Text] [Related]
[Next] [New Search]
